News - Inovio Pharmaceuticals

Filter

Current filters:

Inovio Pharmaceuticals

Popular Filters

Inovio Pharmaceuticals appoints EJ Brandreth as vice president of quality

Inovio Pharmaceuticals appoints EJ Brandreth as vice president of quality

01-04-2014

USA-based Inovio Pharmaceuticals (NYSE MKT: INO) has announced the appointment of EJ Brandreth as Vice…

BoardroomInovio PharmaceuticalsPharmaceuticalUSA

Inovio announces new additions to senior management team

Inovio announces new additions to senior management team

18-02-2014

US drug developer Inovio Pharmaceuticals has expanded its senior management team with two appointments…

BoardroomImmunologicalsInovio PharmaceuticalsPharmaceuticalUSA

Inovio reveals success in DNA plasmid technology

Inovio reveals success in DNA plasmid technology

25-09-2013

US drug developer Inovio Pharmaceuticals has demonstrated the success of its new DNA plasmid technology…

Anti-Arthritics/RheumaticsBiotechnologyCNS DiseasesInovio PharmaceuticalsNorth AmericaOncologyResearch

Roche in up to $422.5 million deal with Inovio Pharma

11-09-2013

Swiss drug major Roche (ROG: SIX) has signed an exclusive, worldwide license agreement with US drug developer…

Anti-viralsINO-1800INO-5150Inovio PharmaceuticalsLicensingOncologyPharmaceuticalRoche

PATH MVI links with Inovio on malaria vaccines and delivery technology

07-01-2013

The USA-based PATH Malaria Vaccine Initiative (MVI) has announced a follow-on collaboration with drugmaker…

Inovio PharmaceuticalsPharmaceuticalResearchTropical diseasesVaccines

Biotron shares leap 29% on hepatitis C Ph IIa positive results; Inovio advances hepatitis vaccines

11-10-2011

Australian firm Biotron (ASX: BIT) has received some strong support in the first couple of hours of market…

Anti-viralsBiotronInovio PharmaceuticalsLicensingPharmaceuticalResearchVaccinesVGX International

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top